Mostrando 10 resultados de: 26
Filtros aplicados
Publisher
New England Journal of Medicine(4)
The Lancet(4)
Diabetes Care(2)
International Journal of Cardiology(2)
Canadian Journal of Cardiology(1)
Área temáticas
Medicina y salud(14)
Farmacología y terapéutica(9)
Problemas sociales y servicios a grupos(9)
Salud y seguridad personal(7)
Fisiología humana(5)
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation
ReviewAbstract: Hypertension is a leading risk factor for disease burden globally. An unresolved question is whetherPalabras claves:Autores:Aguirre-Palacios F., Alcocer L., Barbosa E.C.D., Bertomeu-Martinez V., Bryce-Moncloa A., Burrell L.M., Coca A., Duenas-Herrera A., Kones R., Lanas F., Landrove O., Lavie C.J., Machado C.A., Morales Salinas A., Olsen M.H., Ordunez P., Orias M., Ortellado J., Parra-Carrillo J.Z., PATRICIO LOPEZ -JARAMILLO, Perez G., Pineiro D.J., Piskorz D.L., Prabhakaran D., Ramírez A.J., Redon J., Rodriguez Portelles A., Rodriguez-Leyva D., Sabio R., Sanchez R.A., Schutte A.E., Sebba-Barroso W.K., Sobrino J., Sundström J., Ventura H., Waisman G., Wang J.G., Weber M.A., Yano Y., Yusuf S., Zanchetti A.Fuentes:googlescopusAssociation of Sitting Time with Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries
ArticleAbstract: Importance: High amounts of sitting time are associated with increased risks of cardiovascular diseaPalabras claves:Autores:Abat M.E.M., Alhabib K.F., Avezum A.J., Bangdiwala S.I., Basiak-Rasała A., Chifamba J., Dans A.M., DIaz R., Gupta R., Hu B., Iqbal R., Kelishadi R., Khatib R., Lakshmi P.V.M., Lanas F., Leach L., Lear S.A., Li S., Li W., Mazapuspavina M.Y., Mony P.K., Oguz A., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Wielgosz A., Yeates K.E., Yin L., Yusuf S., Yusufali A.M.Fuentes:googlescopusAssociation of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study
ArticleAbstract: Background: The triglyceride glucose (TyG) index is an easily accessible surrogate marker of insulinPalabras claves:Autores:Abat M.E.M., Alhabib K.F., Avezum A.J., Barbarash O., Chifamba J., Diaz M.L., Gomez-Arbelaez D., Gulec S., Iqbal R., Ismail N., Kelishadi R., Khatib R., Lanas F., Levitt N.S., Li Y., Martínez-Bello D.A., Mohan V., Mony P.K., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rangarajan S., Rosengren A., Soman B., Wang C., Wang Y., Yeates K., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusAssociation of urinary sodium and potassium excretion with blood pressure
ArticleAbstract: BACKGROUND: Higher levels of sodium intake are reported to be associated with higher blood pressure.Palabras claves:Autores:Avezum A.J., Chifamba J., Devanath A., Di C., DIaz R., Iqbal R., Kelishadi R., Khatib R., Lanas F., Li W., McQueen M.J., Mente A., Mony P.K., Morrison H., Noorhassim I., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Poirier P., Puoane T., Rangarajan S., Rosengren A., Teo K.K., Wang X., Wielgosz A., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusAssociations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study
ArticleAbstract: Background & Aims: Several medications have been suspected to contribute to the etiology of inflammaPalabras claves:Antibiotics, Crohn's disease, Estrogen, Hormone, IBD, NSAIDS, Oral Contraceptive, Ulcerative ColitisAutores:Al Sharief W., Alhabib K.F., Ariffin F., Avezum A.J., Bahonar A., Co H.U., Davletov K., Diaz M.L., Erkin M., Iqbal R., Islam S., Khatib R., Kontsevaya A., Kruger L., Lanas F., Li Y., Marshall J.K., Moayyedi P., Narula N., Oguz A., PATRICIO LOPEZ -JARAMILLO, Pray C., Rangarajan S., Reinisch W., Rosengren A., Soman B., Szuba A., Wang C., Wielgosz A., Wong E.C.L., Yeates K., Yin L., Yusuf R., Yusuf S.Fuentes:googlescopusAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAtherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)
ArticleAbstract: This is an executive summary made by a group of experts named Latin American Academy for the study oPalabras claves:Autores:Acevedo M., Alonso R., Arocha I., Bryce A., Carlos Ernesto Peñaherrera, Carrera C., Chirinos J.A., Cobos L., Colan J., Gómez-Alvares E., Gómez-M J.R., Isea-Perez J.E., Lanas F., Lara J., Lorenzatti A.J., Lozada A.F., Machado-H L.T., Medina J., Medina-Palomin F., Merchan-V A., Morales E., Paniagua M., PATRICIO LOPEZ -JARAMILLO, Pinto X., Piskorz D.L., Ponte-Negretti C.I., Ullauri V.E., Varleta P., Villar-M R.A., Wyss-Q F.S.Fuentes:scopusCardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE)
ArticleAbstract: OBJECTIVE: The Outcome Reduction With Initial Glargine Intervention (ORIGIN) trial reported neutralPalabras claves:Autores:Abdallah A., Ahmad S., AHUAD GUERRERO R.A., Alebuena A., Alvarez N., Alzogaray M., Amuchastegui M., Andres M., Angos M., Avezum A.J., Baglivo H., Bahit M.C., Barbieri M., Bassi F., Bello F., Birkeland K.I., Bogaty P.M., Bono J., Bordeleau L., Bosch J.J., Budaj A.J., Bustamante Labarta M., Bustos B., Cardona E., Chacόn C., Chandra J., Chandra R., Chazova I.E., Commerford P.J., Corson M., Cukierman-Yaffee T., Dagenais G.R., Danilova L., Davies M., DIaz R., Dyal L., Fernando R., Fodor G.J., Gerstein H.C., Gilbert R., Gomis R., Halon D., Hâncu N., Hanefeld M., Harper W.L., Hildebrandt P., Johnston P., Joldersma L., Jung H., Kacerovsky-Bielesz G., Keltai M., Kim J.H., Krum H., Kultursay H., Lanas F., Lewis B.S., Lonn E.M., MacRae L., MacRae S., Maggioni A.P., Magloire P., Malik S., Mann J.F.E., Marin-Neto J.A., Marre M., McKelvie R., McQueen M.J., Mead A., Mendoza I., Morillo C.A., Pan C., Pasha F., PATRICIO LOPEZ -JARAMILLO, Pavlova V., Pazmino-Canizares J., Pirags V., Pogue J., Pohl K., Probstfield J.L., Profozic V., Punthakee Z., Ramachandran A., Ratner R., Richardson L., Riddle M.C., Rosenstock J., Rydén L.E., Sakalas A., Silva J., Spinas G.A., Sreenan S., Stoel I., Syvänne M., Tsang B., Tyrwhitt J., Vige R., Yakubovich N., Yale J.F., Yusuf S.Fuentes:scopusCardiovascular risk and events in 17 low-, middle-, and high-income countries
ArticleAbstract: BACKGROUND: More than 80% of deaths from cardiovascular disease are estimated to occur in low-incomePalabras claves:Autores:Anand S.S., Avezum A.J., Bo J., Chifamba J., Dagenais G.R., DIaz R., Gupta R., Iqbal R., Islam S., Kelishadi R., Kruger A., Kumar R., Lanas F., Lear S.A., Li W., Liu L., Liu T., Lou Q., Lu F., Mckee M., McQueen M.J., Mohan V., Mony P.K., Noorhassim I., Oguz A., PATRICIO LOPEZ -JARAMILLO, Puoane T., Rahman O., Rangarajan S., Rosengren A., Swaminathan S., Szuba A., Teo K.K., Vijayakumar K., Wielgosz A., Yu L., Yusoff K., Yusuf S., Yusufali A.M., Zhang S.Fuentes:googlescopusDesign and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
ArticleAbstract: The aim was to determine the effects of dulaglutide, a synthetic once-weekly, injectable human glucaPalabras claves:antidiabetic drug, Cardiovascular disease, Clinical trial, diabetes complications, GLP-1 receptor agonistAutores:Atisso C.M., Avezum A.J., Basile J.N., Cardona-Munoz E.G., Chung N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., DIaz R., Franek E., Gerstein H.C., Hâncu N., Hanefeld M., Holt S., Jansky P., Keltai M., Lakshmanan M., Lanas F., Leiter L.A., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Xavier D.Fuentes:scopus